New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

45

Celularity warns of potential layoffs in strategic review

“As we invest to scale production of our commercial biomaterial products to meet expected demand in the United States and the Middle East, we are prioritizing our most promising cell therapy product candidates and programs and are rebalancing our workforce and identifying targeted expense reductions to support these priorities,” said CEO Robert J. Hariri.

50

Precision Value & Health Names Doug Fulling President

As the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Fulling will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise.